Literature DB >> 2312724

Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6.

H Loppnow1, P Libby.   

Abstract

The cells that make up blood vessel walls appear to participate actively in local immune and inflammatory responses, as well as in certain vascular diseases. We tested here whether smooth muscle cells (SMC) can produce the important inflammatory mediator IL6. Unstimulated SMC in vitro elaborated 5 X 10(3) pg recIL6/24h (i.e., biological activity equivalent to 5 X 10(3) pg recombinant IL6 (recIL6), as determined in B9-assay with a recIL6 standard). Several pathophysiologically relevant factors augmented IL6 release from SMC including 10 micrograms LPS/ml (10(4) pg recIL6), 10 ng tumor necrosis factor/ml (4 X 10(4) pg recIL6), and most notably 10 ng IL1/ml (greater than or equal to 3.2 X 10(5) pg recIL6). Production of IL6 activity corresponded to IL6 mRNA accumulation and de novo synthesis. SMC released newly synthesized IL6 rapidly, as little metabolically labeled material remained cell-associated. In supernatants of IL1-stimulated SMC, IL6 accounted for as much as 4% of the secreted proteins. In normal vessels SMC seldom divide, but SMC proliferation can occur in hypertension or during atherogenesis. We therefore tested the relationship between IL6 production and SMC proliferation in response to platelet-derived growth factor (PDGF) in vitro. Quiescent SMC released scant IL6 activity, whereas PDGF (1-100 ng/ml) produced concentration-dependent and coordinate enhancement of SMC proliferation and IL6 release (linear regression of growth vs. IL6 release yielded r greater than 0.9). IL6 itself neither stimulated nor inhibited SMC growth or IL6 production. Intact medial strips studied in short-term organoid culture produced large quantities of IL6, similar to the results obtained with cultured SMC. These findings illustrate a new function of vascular SMC by which these cells might participate in local immunoregulation and in the pathogenesis of various important vascular diseases as well as in inflammatory responses generally.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2312724      PMCID: PMC296489          DOI: 10.1172/JCI114498

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  59 in total

1.  Systemic mononuclear-cell vasculitis in MRL/Mp-lpr/lpr mice. A histologic and immunocytochemical analysis.

Authors:  C F Moyer; J D Strandberg; C L Reinisch
Journal:  Am J Pathol       Date:  1987-05       Impact factor: 4.307

2.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

3.  Detection of activated T lymphocytes in the human atherosclerotic plaque.

Authors:  G K Hansson; J Holm; L Jonasson
Journal:  Am J Pathol       Date:  1989-07       Impact factor: 4.307

4.  Anti-beta-interferon antibodies inhibit the increased expression of HLA-B7 mRNA in tumor necrosis factor-treated human fibroblasts: structural studies of the beta 2 interferon involved.

Authors:  L T May; D C Helfgott; P B Sehgal
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

5.  Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells.

Authors:  P Libby; J M Ordovas; K R Auger; A H Robbins; L K Birinyi; C A Dinarello
Journal:  Am J Pathol       Date:  1986-08       Impact factor: 4.307

6.  Characterization of a novel murine T cell-activating factor.

Authors:  R D Garman; D H Raulet
Journal:  J Immunol       Date:  1987-02-15       Impact factor: 5.422

7.  Induction and regulation of mRNA encoding 26-kDa protein in human cell lines treated with recombinant human tumor necrosis factor.

Authors:  P Defilippi; P Poupart; J Tavernier; W Fiers; J Content
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

8.  Inducible interleukin-1 gene expression in human vascular smooth muscle cells.

Authors:  P Libby; J M Ordovas; L K Birinyi; K R Auger; C A Dinarello
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

9.  Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin.

Authors:  T Hirano; K Yasukawa; H Harada; T Taga; Y Watanabe; T Matsuda; S Kashiwamura; K Nakajima; K Koyama; A Iwamatsu
Journal:  Nature       Date:  1986 Nov 6-12       Impact factor: 49.962

10.  Structure and expression of cDNA and genes for human interferon-beta-2, a distinct species inducible by growth-stimulatory cytokines.

Authors:  A Zilberstein; R Ruggieri; J H Korn; M Revel
Journal:  EMBO J       Date:  1986-10       Impact factor: 11.598

View more
  88 in total

Review 1.  The biology of endotoxin.

Authors:  H Heine; E T Rietschel; A J Ulmer
Journal:  Mol Biotechnol       Date:  2001-11       Impact factor: 2.695

2.  Opposing roles of RAGE and Myd88 signaling in extensive liver resection.

Authors:  Shan Zeng; Qing Yin Zhang; Jianzhong Huang; Srinivasan Vedantham; Rosa Rosario; Radha Ananthakrishnan; Shi Fang Yan; Ravichandran Ramasamy; Ronald P DeMatteo; Jean C Emond; Richard A Friedman; Ann Marie Schmidt
Journal:  FASEB J       Date:  2011-11-10       Impact factor: 5.191

Review 3.  Cardiac biomarkers: new tools for heart failure management.

Authors:  Navaid Iqbal; Bailey Wentworth; Rajiv Choudhary; Alejandro De La Parra Landa; Benjamin Kipper; Arrash Fard; Alan S Maisel
Journal:  Cardiovasc Diagn Ther       Date:  2012-06

Review 4.  Vascular smooth muscle cells in cerebral aneurysm pathogenesis.

Authors:  Robert M Starke; Nohra Chalouhi; Dale Ding; Daniel M S Raper; M Sean Mckisic; Gary K Owens; David M Hasan; Ricky Medel; Aaron S Dumont
Journal:  Transl Stroke Res       Date:  2013-10-10       Impact factor: 6.829

5.  Intracellular interleukin 6 mediates platelet-derived growth factor-induced proliferation of nontransformed cells.

Authors:  M Roth; M Nauck; M Tamm; A P Perruchoud; R Ziesche; L H Block
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

6.  Human atherosclerotic abdominal aortic aneurysms produce interleukin (IL)-6 and interferon-gamma but not IL-2 and IL-4: the possible role for IL-6 and interferon-gamma in vascular inflammation.

Authors:  Z Szekanecz; M R Shah; W H Pearce; A E Koch
Journal:  Agents Actions       Date:  1994-10

7.  Localization of T lymphocytes and macrophages expressing IL-1, IL-2 receptor, IL-6 and TNF in human aortic intima. Role of cell-mediated immunity in human atherogenesis.

Authors:  H Kishikawa; T Shimokama; T Watanabe
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

Review 8.  The role of CD14 and lipopolysaccharide-binding protein (LBP) in the activation of different cell types by endotoxin.

Authors:  R R Schumann; E T Rietschel; H Loppnow
Journal:  Med Microbiol Immunol       Date:  1994-12       Impact factor: 3.402

9.  Enhanced production of the chemotactic cytokines interleukin-8 and monocyte chemoattractant protein-1 in human abdominal aortic aneurysms.

Authors:  A E Koch; S L Kunkel; W H Pearce; M R Shah; D Parikh; H L Evanoff; G K Haines; M D Burdick; R M Strieter
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

10.  Genetic engineering of vein grafts resistant to atherosclerosis.

Authors:  M J Mann; G H Gibbons; R S Kernoff; F P Diet; P S Tsao; J P Cooke; Y Kaneda; V J Dzau
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.